11/13
07:40 am
qttb
Q32 Bio GAAP EPS of -$0.60 beats by $0.59 [Seeking Alpha]
Medium
Report
Q32 Bio GAAP EPS of -$0.60 beats by $0.59 [Seeking Alpha]
11/13
06:59 am
qttb
Q32 Bio Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Medium
Report
Q32 Bio Reports Third Quarter 2025 Financial Results and Provides Corporate Update
10/26
01:08 am
qttb
Medium
Report
10/21
06:59 am
qttb
Q32 Bio Announces Completion of Enrollment in Part B of SIGNAL-AA Phase 2a Clinical Trial of Bempikibart for Alopecia Areata
High
Report
Q32 Bio Announces Completion of Enrollment in Part B of SIGNAL-AA Phase 2a Clinical Trial of Bempikibart for Alopecia Areata
10/4
12:06 am
qttb
Medium
Report